Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-1010
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD ; volume:28 ; number:1 ; day:27 ; month:8 ; year:2018 ; pages:1-9 ; date:12.2018
npj Primary care respiratory medicine ; 28, Heft 1 (27.8.2018), 1-9, 12.2018
- Urheber
-
Han, MeiLan K.
- Beteiligte Personen und Organisationen
-
Ray, Riju
Foo, Jason
Morel, Chaienna
Hahn, Beth
SpringerLink (Online service)
- DOI
-
10.1038/s41533-018-0099-1
- URN
-
urn:nbn:de:101:1-2018092810115613556557
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Han, MeiLan K.
- Ray, Riju
- Foo, Jason
- Morel, Chaienna
- Hahn, Beth
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repurposing FDA-approved drugs for anti-aging therapies
Alternative pre-approved and novel therapies for the treatment of anthrax
Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Tested & Approved
Tested & Approved
Tested & Approved
Tested & approved
Tested & Approved
"Approved Applicant"
Tested & approved
Tested & approved
Repurposing FDA-approved drugs for anti-aging therapies
Alternative pre-approved and novel therapies for the treatment of anthrax
Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Tested & Approved
Tested & Approved
Tested & Approved
Tested & approved
Tested & Approved
"Approved Applicant"
Tested & approved
Tested & approved
Repurposing FDA-approved drugs for anti-aging therapies
Alternative pre-approved and novel therapies for the treatment of anthrax
Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Tested & Approved
Tested & Approved
Tested & Approved
Tested & approved
Tested & Approved
"Approved Applicant"
Tested & approved